TheraRadar
← Back
Data updated: Mar 29, 2026

AARXION ANDA HLDING

ImmunologyGastroenterology
Specialty

AARXION ANDA HLDING is a specialty pharmaceutical company focused on Immunology, Gastroenterology.

1981
Since
6
Drugs
-
Trials
26
Approved (2yr)

Key Drugs

No active drugs

Top Drug Revenues Pro

Loading...

Revenue Over Time Pro

Loading...

Recent Activity

OXAPROZIN 2026-01-22
Labeling
EPLERENONE 2025-12-04
Labeling
METFORMIN HYDROCHLORIDE 2025-11-10
Manufacturing (CMC)
METFORMIN HYDROCHLORIDE 2025-06-24
Labeling
METFORMIN HYDROCHLORIDE 2025-06-24
Labeling
BALSALAZIDE DISODIUM 2025-06-23
Labeling
BALSALAZIDE DISODIUM 2025-06-23
Labeling
METFORMIN HYDROCHLORIDE 2025-04-14
SEC Filings Pro
Loading...

Therapeutic Areas

Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5

Immunology 50%
2 drugs
Gastroenterology 50%
2 drugs

Pipeline Forecast

Loading...

Upcoming Trial Milestones Pro

Loading...

Patent Cliff Pro

Loading...

Competitors by Therapeutic Area

Pfizer big-pharma
Immunology, Gastroenterology
Bristol-Myers Squibb big-pharma
Immunology, Gastroenterology
BAUSCH specialty
Immunology, Gastroenterology
Takeda big-pharma
Immunology, Gastroenterology
Gilead Sciences biotech
Immunology, Gastroenterology